1. Home
  2. INM vs CNF Comparison

INM vs CNF Comparison

Compare INM & CNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INM
  • CNF
  • Stock Information
  • Founded
  • INM 1981
  • CNF 1999
  • Country
  • INM Canada
  • CNF China
  • Employees
  • INM N/A
  • CNF N/A
  • Industry
  • INM Biotechnology: Pharmaceutical Preparations
  • CNF Finance: Consumer Services
  • Sector
  • INM Health Care
  • CNF Finance
  • Exchange
  • INM Nasdaq
  • CNF Nasdaq
  • Market Cap
  • INM 3.2M
  • CNF 35.7M
  • IPO Year
  • INM N/A
  • CNF 2018
  • Fundamental
  • Price
  • INM $2.90
  • CNF $0.74
  • Analyst Decision
  • INM
  • CNF
  • Analyst Count
  • INM 0
  • CNF 0
  • Target Price
  • INM N/A
  • CNF N/A
  • AVG Volume (30 Days)
  • INM 5.7M
  • CNF 288.0K
  • Earning Date
  • INM 05-12-2025
  • CNF 08-27-2025
  • Dividend Yield
  • INM N/A
  • CNF N/A
  • EPS Growth
  • INM N/A
  • CNF N/A
  • EPS
  • INM N/A
  • CNF 0.08
  • Revenue
  • INM $4,920,990.00
  • CNF $85,661,735.00
  • Revenue This Year
  • INM N/A
  • CNF $252.34
  • Revenue Next Year
  • INM N/A
  • CNF N/A
  • P/E Ratio
  • INM N/A
  • CNF $10.20
  • Revenue Growth
  • INM N/A
  • CNF N/A
  • 52 Week Low
  • INM $1.72
  • CNF $0.37
  • 52 Week High
  • INM $15.70
  • CNF $2.84
  • Technical
  • Relative Strength Index (RSI)
  • INM 50.30
  • CNF 68.40
  • Support Level
  • INM $2.93
  • CNF $0.42
  • Resistance Level
  • INM $5.50
  • CNF $0.82
  • Average True Range (ATR)
  • INM 0.36
  • CNF 0.08
  • MACD
  • INM 0.01
  • CNF 0.03
  • Stochastic Oscillator
  • INM 22.22
  • CNF 87.18

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

About CNF CNFinance Holdings Limited each representing twenty (20)

CNFinance Holdings Ltd is an equity loan service provider. It focuses on the development of small and micro-enterprises. It generates revenue in the form of interest and financing service fees on loans and interest on deposits with banks. Its primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. Geographically, it has an operation in PRC.

Share on Social Networks: